494 related articles for article (PubMed ID: 26033719)
1. Mycobacterium tuberculosis folate metabolism and the mechanistic basis for para-aminosalicylic acid susceptibility and resistance.
Minato Y; Thiede JM; Kordus SL; McKlveen EJ; Turman BJ; Baughn AD
Antimicrob Agents Chemother; 2015 Sep; 59(9):5097-106. PubMed ID: 26033719
[TBL] [Abstract][Full Text] [Related]
2. The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria.
Rengarajan J; Sassetti CM; Naroditskaya V; Sloutsky A; Bloom BR; Rubin EJ
Mol Microbiol; 2004 Jul; 53(1):275-82. PubMed ID: 15225321
[TBL] [Abstract][Full Text] [Related]
3. Methionine Antagonizes
Howe MD; Kordus SL; Cole MS; Bauman AA; Aldrich CC; Baughn AD; Minato Y
Front Cell Infect Microbiol; 2018; 8():399. PubMed ID: 30483484
[No Abstract] [Full Text] [Related]
4. Para-aminosalicylic acid acts as an alternative substrate of folate metabolism in Mycobacterium tuberculosis.
Chakraborty S; Gruber T; Barry CE; Boshoff HI; Rhee KY
Science; 2013 Jan; 339(6115):88-91. PubMed ID: 23118010
[TBL] [Abstract][Full Text] [Related]
5. Binding pocket alterations in dihydrofolate synthase confer resistance to para-aminosalicylic acid in clinical isolates of Mycobacterium tuberculosis.
Zhao F; Wang XD; Erber LN; Luo M; Guo AZ; Yang SS; Gu J; Turman BJ; Gao YR; Li DF; Cui ZQ; Zhang ZP; Bi LJ; Baughn AD; Zhang XE; Deng JY
Antimicrob Agents Chemother; 2014; 58(3):1479-87. PubMed ID: 24366731
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetics of para-aminosalicylic acid resistance in clinical isolates and spontaneous mutants of Mycobacterium tuberculosis.
Mathys V; Wintjens R; Lefevre P; Bertout J; Singhal A; Kiass M; Kurepina N; Wang XM; Mathema B; Baulard A; Kreiswirth BN; Bifani P
Antimicrob Agents Chemother; 2009 May; 53(5):2100-9. PubMed ID: 19237648
[TBL] [Abstract][Full Text] [Related]
7. [Mutations in the thymidylate synthase gene is a major mechanism in the para-aminosalicylic acid resistance of M. tuberculosis].
Zhang ZD; Zhao YL; Li ZH; Jia HY; Liu YH; Chen X; Liu ZQ; Du BP; Xing AY; Ma Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Sep; 30(9):683-5. PubMed ID: 18070553
[TBL] [Abstract][Full Text] [Related]
8. Deletion of
Yang SS; Hu YB; Wang XD; Gao YR; Li K; Zhang XE; Chen SY; Zhang TY; Gu J; Deng JY
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28717039
[TBL] [Abstract][Full Text] [Related]
9. Determination of critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against para-aminosalicylic acid with clinical isolates with thyA, folC and dfrA mutations.
Wang W; Li S; Ge Q; Guo H; Shang Y; Ren W; Wang Y; Xue Z; Lu J; Pang Y
Ann Clin Microbiol Antimicrob; 2022 Nov; 21(1):48. PubMed ID: 36335391
[TBL] [Abstract][Full Text] [Related]
10. Whole genome sequencing reveals candidate genes involving in PAS resistance in M. Tuberculosis isolated from patients in Thailand.
Dokladda K; Billamas P; Jaitrong S; Suwanakitti N; Phornsiricharoenphant W; Viratyosin W; Prammananan T
World J Microbiol Biotechnol; 2023 Dec; 40(1):32. PubMed ID: 38057660
[TBL] [Abstract][Full Text] [Related]
11. Thr202Ala in thyA is a marker for the Latin American Mediterranean lineage of the Mycobacterium tuberculosis complex rather than para-aminosalicylic acid resistance.
Feuerriegel S; Köser C; Trübe L; Archer J; Rüsch Gerdes S; Richter E; Niemann S
Antimicrob Agents Chemother; 2010 Nov; 54(11):4794-8. PubMed ID: 20805400
[TBL] [Abstract][Full Text] [Related]
12. Genetic determinants involved in p-aminosalicylic acid resistance in clinical isolates from tuberculosis patients in northern China from 2006 to 2012.
Zhang X; Liu L; Zhang Y; Dai G; Huang H; Jin Q
Antimicrob Agents Chemother; 2015 Feb; 59(2):1320-4. PubMed ID: 25421465
[TBL] [Abstract][Full Text] [Related]
13. [The rates of resistance to second-line drugs in multidrug resistant Mycobacterium tuberculosis strains].
Kayali R; Cöplü N; Ceyhan I; Ocak F; Citil BE; Esen B
Mikrobiyol Bul; 2006; 40(1-2):1-7. PubMed ID: 16775950
[TBL] [Abstract][Full Text] [Related]
14. Decreased Methylenetetrahydrofolate Reductase Activity Leads to Increased Sensitivity to
Yu JF; Xu JT; Yang SS; Gao MN; Si HR; Xiong DY; Gu J; Wu ZL; Zhou J; Deng JY
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0146521. PubMed ID: 34780266
[TBL] [Abstract][Full Text] [Related]
15. Second-line drug susceptibilities of multidrug-resistant tuberculosis strains isolated in Thailand: an update.
Chaiprasert A; Srimuang S; Tingtoy N; Makhao N; Sirirudeeporn P; Tomnongdee N; Theankeaw O; Charoensook S; Leechawengwongs M; Prammananan T
Int J Tuberc Lung Dis; 2014 Aug; 18(8):961-3. PubMed ID: 25199012
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic Susceptibility Patterns of Mycobacterium tuberculosis Isolates from Guizhou Province of China Against 13 Antituberculosis Drugs.
Li N; Liao X; Chen L; Wang J; Liu M; Zhang H
Microb Drug Resist; 2015 Jun; 21(3):292-6. PubMed ID: 25599413
[TBL] [Abstract][Full Text] [Related]
17. Drugging the Folate Pathway in Mycobacterium tuberculosis: The Role of Multi-targeting Agents.
Hajian B; Scocchera E; Shoen C; Krucinska J; Viswanathan K; G-Dayanandan N; Erlandsen H; Estrada A; Mikušová K; Korduláková J; Cynamon M; Wright D
Cell Chem Biol; 2019 Jun; 26(6):781-791.e6. PubMed ID: 30930162
[TBL] [Abstract][Full Text] [Related]
18. Multi-omics comparisons of p-aminosalicylic acid (PAS) resistance in folC mutated and un-mutated Mycobacterium tuberculosis strains.
Wei W; Yan H; Zhao J; Li H; Li Z; Guo H; Wang X; Zhou Y; Zhang X; Zeng J; Chen T; Zhou L
Emerg Microbes Infect; 2019; 8(1):248-261. PubMed ID: 30866779
[TBL] [Abstract][Full Text] [Related]
19. [M. tuberculosis drug resistance and occurrence in patients with pulmonary tuberculosis].
Novozhylova IO
Lik Sprava; 2003 Dec; (8):16-20. PubMed ID: 14964999
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of orally active prodrugs and analogs of para-aminosalicylic acid (PAS).
Hegde PV; Howe MD; Zimmerman MD; Boshoff HIM; Sharma S; Remache B; Jia Z; Pan Y; Baughn AD; Dartois V; Aldrich CC
Eur J Med Chem; 2022 Mar; 232():114201. PubMed ID: 35219151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
